Rightway Secures $155 Million in Series E Funding
Rightway has raised $155 million in Series E funding led by Francisco Partners, with participation from existing investors Thrive Capital and Khosla Ventures. The investment aims to support the company's growth as it helps employers manage rising pharmacy costs through a model that aligns incentives between providers and clients. The healthcare industry is witnessing rapid cost increases, particularly for prescription drugs, which are expected to be the fastest-growing segment of health spending over the next decade. Rightway’s approach eliminates financial incentives tied to higher drug prices while integrating clinical guidance from pharmacists to help members access appropriate medications at lower costs. Rightway now serves 45 Fortune 500 companies and offers a comprehensive model that includes cost guarantees, AI-driven technology, and pharmacist-led care navigation across the broader healthcare ecosystem.
Topics: healthcare spending pharmacy benefits Series E financing